World's Best Scientists 2026 revealed!
Award Badge
Neuroscience
Austria
2026

D-Index & Metrics

Neuroscience

D-Index
124
Citations
59305
World Ranking
335
National Ranking
5

Siegfried Kasper publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Siegfried Kasper sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 1,726 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Siegfried Kasper D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Siegfried Kasper sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 124 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Neuroscience in Austria Leader Award
  • 2025 - Research.com Neuroscience in Austria Leader Award
  • 2020 - Member of Academia Europaea
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Siegfried Kasper is affiliated with the Medical University of Vienna in Austria and has contributed extensively to the fields of medicine and neuroscience. Their research spans numerous subfields including pharmacology, psychiatry and mental health, experimental and cognitive psychology, cognitive neuroscience, and biological psychiatry.

The main focus of Kasper's work centers on the treatment of major depression, with additional attention to tryptophan and brain disorders, functional brain connectivity studies, mental health research topics, anxiety, depression, psychometrics, treatment, cognitive processes, bipolar disorder and treatment, as well as schizophrenia research and treatment.

Kasper has collaborated frequently with several researchers, notably Rupert Lanzenberger, Lucie Bartova, Daniel Souery, Joseph Zohar, and Alessandro Serretti. These collaborations have contributed to the extensive output of scientific literature.

Their publications are often found in prominent academic journals, with a significant number appearing in venues such as:

  • European Neuropsychopharmacology (12 publications)
  • The International Journal of Neuropsychopharmacology (10 publications)
  • Journal of Affective Disorders (9 publications)
  • The World Journal of Biological Psychiatry (8 publications)
  • International Journal of Psychiatry in Clinical Practice (8 publications)

Some notable recent papers relevant to their research interests include:

  • "Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation" (2021, American Journal of Psychiatry)
  • "Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions" (2023, World Psychiatry)
  • "Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)" (2020, The International Journal of Neuropsychopharmacology)
  • "Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression" (2020, The Journal of Clinical Psychiatry)
  • "The identification, assessment and management of difficult-to-treat depression: An international consensus statement" (2020, Journal of Affective Disorders)

Siegfried Kasper has been recognized with memberships in scholarly communities, including being a member of Academia Europaea since 2020 and a member of the European Academy of Sciences and Arts.

Best Publications

  • Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland.

    Siegfried Kasper;Thomas A. Wehr;John J. Bartko;Paul A. Gaist

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

    Borwin Bandelow;Josef Zohar;Eric Hollander;Siegfried Kasper

  • Social functioning in depression: a review

    Robert M.A. Hirschfeld;Stuart A. Montgomery;Martin B. Keller;Siegfried Kasper

  • Prevalence of seasonal affective disorder at four latitudes.

    Leora N. Rosen;Steven D. Targum;Michael Terman;Michael J. Bryant

  • Updated European Consensus Statement on Diagnosis and Treatment of Adult ADHD

    J.J.S. Kooij;D. Bijlenga;L. Salerno;R. Jaeschke

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S McIntyre;Roger S McIntyre;Joshua D Rosenblat;Joshua D Rosenblat;Charles B Nemeroff;Gerard Sanacora

  • Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

    Daniel Souery;Pierre Oswald;Isabelle Massat;Ursula Bailer

  • CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.

    J Kirchheiner;K Brosen;Marja-Liisa Dahl;LF Gram

  • Prognosis and improved outcomes in major depression: a review

    Christoph Kraus;Christoph Kraus;Bashkim Kadriu;Rupert Lanzenberger;Carlos A. Zarate Jr.

  • The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.

    Heinz Grunze;Eduard Vieta;Guy M Goodwin;Charles Bowden

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.

    Heinz Grunze;Eduard Vieta;Guy M. Goodwin;Charles Bowden

  • A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

    Guy M. Goodwin;Charles L. Bowden;Joseph R. Calabrese;Heinz Grunze

  • Guidelines for the pharmacological treatment of anxiety disorders, obsessive - compulsive disorder and posttraumatic stress disorder in primary care

    Borwin Bandelow;Leo Sher;Robertas Bunevicius;Eric Hollander

  • Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder.

    Andreas Hahn;Patrycja Stein;Christian Windischberger;Andreas Weissenbacher

  • Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression.

    Christoph Kraus;Eero Castrén;Siegfried Kasper;Rupert Lanzenberger

  • Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

    Siegfried Kasper;Mark N. Lerman;Robert D. McQuade;Anutosh Saha

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

    Heinz Grunze;Eduard Vieta;Guy M Goodwin;Charles Bowden

  • The serotonin-1A receptor in anxiety disorders.

    Elena Akimova;Rupert Lanzenberger;Siegfried Kasper

  • Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference.

    Carolina Johansson;Matthäeus Willeit;Christina Smedh;Jenny Ekholm

  • Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder.

    Jean Pierre Olié;Siegfried Kasper

Frequent Co-Authors

Rupert Lanzenberger
Rupert Lanzenberger Medical University of Vienna
Andreas Hahn
Andreas Hahn University of Giessen
Julien Mendlewicz
Julien Mendlewicz Université Libre de Bruxelles
Nicole Praschak-Rieder
Nicole Praschak-Rieder Medical University of Vienna
Stuart Montgomery
Stuart Montgomery Imperial College London
Georg S. Kranz
Georg S. Kranz Hong Kong Polytechnic University
Alessandro Serretti
Alessandro Serretti Kore University of Enna
Alexander Neumeister
Alexander Neumeister Independent Scientist / Consultant, US
Joseph Zohar
Joseph Zohar Sheba Medical Center
Hans-Jürgen Möller
Hans-Jürgen Möller Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience opens doors to a range of online degrees and specialized career options. Many students who pursue neuroscience also consider advanced programs in psychology and therapy. For those interested in clinical practice, there are psyd programs online that offer flexibility for working professionals and those balancing other commitments.

Another valuable pathway is marriage and family therapy. Accredited programs are now more accessible than ever, with online mft programs accredited for faster entry into the field. These programs can be a great fit for neuroscience graduates wanting to work directly with clients in counseling or therapy roles.

Those looking to start their career sooner may benefit from accelerated bachelors degrees that shorten the time to graduation without compromising educational quality. These fast-track options can be particularly helpful for adult learners returning to education or those seeking a career change.

Finally, if earning potential is a priority, it's smart to research the highest paying bachelor degrees in fields related to neuroscience and psychology. This ensures your educational investment aligns with your long-term career and financial goals.

Best Scientists Citing Siegfried Kasper

Trending Scientists

Recently Published Articles